FCCC LOGO Faculty Publications
Motzer RJ , Jonasch E , Boyle S , Carlo MI , Manley B , Agarwal N , Alva A , Beckermann K , Choueiri TK , Costello BA , Derweesh IH , Desai A , George S , Gore JL , Haas N , Hancock SL , Kyriakopoulos C , Lam ET , Lau C , Lewis B , Madoff DC , McCreery B , Michaelson MD , Mortazavi A , Nandagopal L , Pierorazio PM , Plimack ER , Ponsky L , Ramalingam S , Shuch B , Smith ZL , Somer B , Sosman J , Dwyer MA , Motter AD
NCCN Guidelines Insights: Kidney Cancer, Version 1.2021
J Natl Compr Canc Netw. 2020 Sep;18(9) :1160-1170
Back to previous list
Abstract
The NCCN Guidelines for Kidney Cancer provide multidisciplinary recommendations for diagnostic workup, staging, and treatment of patients with renal cell carcinoma (RCC). These NCCN Guidelines Insights focus on recent updates to the guidelines, including changes to certain systemic therapy recommendations for patients with relapsed or stage IV RCC. They also discuss the addition of a new section to the guidelines that identifies and describes the most common hereditary RCC syndromes and provides recommendations for genetic testing, surveillance, and/or treatment options for patients who are suspected or confirmed to have one of these syndromes.
Notes
Motzer, Robert J Jonasch, Eric Boyle, Shawna Carlo, Maria I Manley, Brandon Agarwal, Neeraj Alva, Ajjai Beckermann, Katy Choueiri, Toni K Costello, Brian A Derweesh, Ithaar H Desai, Arpita George, Saby Gore, John L Haas, Naomi Hancock, Steven L Kyriakopoulos, Christos Lam, Elaine T Lau, Clayton Lewis, Bryan Madoff, David C McCreery, Brittany Michaelson, M Dror Mortazavi, Amir Nandagopal, Lakshminarayanan Pierorazio, Phillip M Plimack, Elizabeth R Ponsky, Lee Ramalingam, Sundhar Shuch, Brian Smith, Zachary L Somer, Bradley Sosman, Jeffrey Dwyer, Mary A Motter, Angela D eng J Natl Compr Canc Netw. 2020 Sep;18(9):1160-1170. doi: 10.6004/jnccn.2020.0043.